Sunshine Biopharma Inc [NASDAQ: SBFM] traded at a high on Tuesday, posting a 28.89 gain after which it closed the day’ session at $0.39.
The results of the trading session contributed to over 8441959 shares changing hands. Over the past one week, the price volatility of Sunshine Biopharma Inc stands at 29.05% while the volatility over the past one month is 16.50%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for SBFM stock reached $7.41 million, with 18.95 million shares outstanding and 18.90 million shares in the current float. Compared to the average trading volume of 3.83M shares, SBFM reached a trading volume of 8441959 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Sunshine Biopharma Inc [SBFM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SBFM shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SBFM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Sunshine Biopharma Inc is set at 0.19, with the Price to Sales ratio for SBFM stock in the period of the last 12 months amounting to 0.28. The Price to Book ratio for the last quarter was 0.02, with the Price to Cash per share for the same quarter was set at 0.92.
How has SBFM stock performed recently?
Sunshine Biopharma Inc [SBFM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.79. With this latest performance, SBFM shares dropped by -57.98% in over the last four-week period, additionally sinking by -98.36% over the last 6 months – not to mention a drop of -99.27% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SBFM stock in for the last two-week period is set at 32.84, with the RSI for the last a single of trading hit 36.86, and the three-weeks RSI is set at 33.31 for Sunshine Biopharma Inc [SBFM]. The present Moving Average for the last 50 days of trading for this stock 1.7720, while it was recorded at 0.3404 for the last single week of trading, and 17.8293 for the last 200 days.
Sunshine Biopharma Inc [SBFM]: Deeper insight into the fundamentals
Sunshine Biopharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.23 and a Current Ratio set at 4.41.
Insider trade positions for Sunshine Biopharma Inc [SBFM]
The top three institutional holders of SBFM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in SBFM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in SBFM stock with ownership which is approximately 5.8386%.
